Related Experiment Video
Updated: Dec 14, 2025

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
COVID-19-related encephalopathy responsive to high-dose glucocorticoids
Deborah Pugin1, Maria-Isabel Vargas1, Camille Thieffry1
1From the Department of APSI (D.P., C.T., J.P.), Intensive Care Unit, Geneva University Hospital; Diagnostic Department (M.-I.V.), Division of Neuroradiology, Geneva University Hospital; Medicine Department (M.S.), Division of Infectiology, Geneva University Hospital; Medicine Department (O.G.), Division of Internal Medicine, Geneva University Hospital; Department of Clinical Neurosciences (P.H.L.), Division of Neurology, Geneva University Hospital; Diagnostic Department (P.H.L.), Division of Laboratory Medicine, Geneva University Hospital; and Department of Pathology and Immunology (P.H.L.), Faculty of Medicine, University of Geneva, Geneva, Switzerland.
No abstract available in PubMed .
More Related Videos
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
08:20Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
Published on: June 2, 2022
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Antiepileptic Drugs: Glutamate Antagonists